Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin

被引:0
|
作者
N Byts
A Samoylenko
T Fasshauer
M Ivanisevic
L Hennighausen
H Ehrenreich
A-L Sirén
机构
[1] Section of Experimental Neurosurgery,Department of Neurosurgery
[2] University of Würzburg,Division of Clinical Neuroscience
[3] Max-Planck-Institute of Experimental Medicine,undefined
[4] Laboratory of Genetics and Physiology,undefined
[5] National Institute of Diabetes,undefined
[6] Digestive and Kidney Diseases,undefined
[7] National Institutes of Health,undefined
来源
Cell Death & Differentiation | 2008年 / 15卷
关键词
process length; ifenprodil; -AP-5; cucurbitacin I; LY294002; NMDA;
D O I
暂无
中图分类号
学科分类号
摘要
The transcription factors signal transducer and activator of transcription 5a and 5b (Stat5) are activated by the neuroprotective and neurotrophic cytokines, erythropoietin (EPO) and growth hormone (GH). Here, we show a dissociation of the intracellular pathway mediating the protective effect of EPO against glutamate toxicity from that needed for its neurotrophic activity using hippocampal neuronal cultures from Stat5a/b-knockout (Stat5−/−) mouse fetuses. Both pretreatment and post-treatment with EPO counteracted glutamate-induced cell death in Stat5+/+ and Stat5−/− neurons. Acute pharmacological inhibition of Janus kinase 2 (JAK2)/Stat signalling had no effect on EPO neuroprotection, whereas inhibition of phosphatidylinositol-3′ kinase (PI3K)/Akt pathway abolished the protective effect of EPO in both Stat5+/+ and Stat5−/− neurons. GH effectively protected Stat5+/+ cells against glutamate toxicity but had no effect in Stat5−/− neurons or in Stat5+/+ neurons treated with JAK2/Stat or PI3K inhibitor. EPO and GH stimulated neurite outgrowth and branching of Stat5+/+ neurons by activating PI3K/Akt signalling but had no trophic effect in Stat5−/− cells. We conclude that in hippocampal neurons, Stat5 is not required for neuroprotection by EPO but is together with Akt essential for its neurotrophic activity. Both Stat5 and Akt are needed for neuroprotective and neurotrophic signalling of GH in neurons.
引用
收藏
页码:783 / 792
页数:9
相关论文
共 50 条
  • [1] Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin
    Byts, N.
    Samoylenko, A.
    Fasshauer, T.
    Ivanisevic, M.
    Hennighausen, L.
    Ehrenreich, H.
    Siren, A-L
    CELL DEATH AND DIFFERENTIATION, 2008, 15 (04): : 783 - 792
  • [2] STAT5 as a Key Protein of Erythropoietin Signalization
    Tothova, Zuzana
    Tomc, Jana
    Debeljak, Natasa
    Solar, Peter
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (13)
  • [3] Effect of erythropoietin on Leydig cell is associated with the activation of Stat5 pathway
    Yamazaki, T
    Kanzaki, M
    Kamidono, S
    Fujisawa, M
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2004, 213 (02) : 193 - 198
  • [4] A possible role of Stat5 in erythropoietin-induced erythroid differentiation.
    Chida, D
    Wakao, H
    Damen, JE
    Krystal, G
    Miyajima, A
    BLOOD, 1996, 88 (10) : 2623 - 2623
  • [5] A mechanism of erythropoietin-dependent STAT5 activation and it's role in apoptosis.
    Sawyer, ST
    Penta, K
    BLOOD, 1995, 86 (10) : 58 - 58
  • [6] Association of JAK2 and STAT5 with erythropoietin receptors - Role of receptor phosphorylation in erythropoietin signal transduction
    Sawyer, ST
    Penta, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (50) : 32430 - 32437
  • [7] ROLE OF STAT5 IN LIVER FIBROSIS
    Blaas, L.
    Kornfield, J. -W
    Zollner, G.
    Schramek, D.
    Esterbauer, H.
    Trauner, M.
    Casanova, E.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S109 - S109
  • [8] STAT5 inhibitor attenuates atherosclerosis via inhibition of inflammation: the role of STAT5 in atherosclerosis
    Wang, Xiaodong
    Ding, Xiaoji
    Yan, Jin
    Lu, Ziying
    Cao, Haoyang
    Ni, Xiaolong
    Ying, Yin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (03): : 1422 - 1431
  • [9] Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway
    Chin, H
    Arai, A
    Wakao, H
    Kamiyama, R
    Miyasaka, N
    Miura, O
    BLOOD, 1998, 91 (10) : 3734 - 3745
  • [10] STAT5 and STAT5 Inhibitors in Hematological Malignancies
    Tolomeo, Manlio
    Meli, Maria
    Grimaudo, Stefania
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (17) : 2036 - 2046